Study guide
Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness
EBP-EAP Examination in Paediatrics Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Governance, Ethics & Child Safeguarding
EBP-EAP Format, Delivery, Scoring, and Clinical Vignette Strategy Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety Child Protection, Physical/Emotional Abuse, Neglect, and Non-Accidental Injury (NAI)
2 Chapter 2: Neonatal Transition, Resuscitation & Prematurity
Delivery Room Care, Apgar Scoring, and Neonatal Resuscitation Algorithm Respiratory Distress Syndrome (RDS), Surfactant Therapy, and Bronchopulmonary Dysplasia Perinatal Asphyxia, HIE Sarnat Staging, and Therapeutic Hypothermia Protocol
3 Chapter 3: Neonatal Morbidities, Jaundice & Congenital Infections
Unconjugated vs Conjugated Hyperbilirubinemia, Phototherapy Thresholds, and Exchange Transfusion Early- vs Late-Onset Sepsis, Group B Streptococcus, and Congenital TORCH Infections NEC Diagnosis/Bell Staging, Neonatal Hypoglycaemia, and Newborn Bloodspot Screening
4 Chapter 4: Acute Paediatric Emergencies & Critical Care
EPLS/PALS Structured Approach, Types of Shock, and Weight-Based Fluid Boluses Clinical Diagnostic Criteria, Intramuscular Adrenaline Dosing, and Refractory Anaphylaxis 5-Minute Time-Critical Anticonvulsant Protocol and Status Epilepticus Care Common Toxidromes (Paracetamol, Iron, Caustics, Button Batteries) and Decontamination
5 Chapter 5: Paediatric Respiratory Medicine
Stridor Differential, Croup (Westley Score & Dexamethasone), and Epiglottitis RSV Pathogenesis, Supportive Management, Oxygen/High-Flow Criteria, and Futility of Bronchodilators/Steroids European/BTS Guidelines on Chronic Stepwise Control and Acute Severe Exacerbation Management Community-Acquired Pneumonia Etiology, Parapneumonic Effusion/Empyema, and Cystic Fibrosis Pulmonary Exacerbations
6 Chapter 6: Paediatric Cardiology
Acyanotic vs Cyanotic Congenital Heart Disease: Ductal Patency, Shunt Lesions, and Emergency Stabilization Paediatric Murmurs and Arrhythmias: Innocent vs Pathological Murmurs, SVT, and Resuscitation Protocols Acquired Heart Disease: Kawasaki Disease, Coronary Aneurysm Prevention, and Acute Rheumatic Fever
7 Chapter 7: Paediatric Gastroenterology, Hepatology & Nutrition
Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols ESPGHAN Coeliac Diagnostic Criteria (Biopsy-Sparing Pathway) and Paediatric Crohn's/Ulcerative Colitis Breastfeeding, Formula Selection, Cow's Milk Protein Allergy (CMPA), GERD vs GOR, and Faltering Growth Prolonged Neonatal Jaundice Workup, Biliary Atresia Red Flags, and Acute Hepatitis/Liver Failure
8 Chapter 8: Paediatric Nephrology, Fluids & Electrolyte Balance
Paediatric UTI Diagnosis, Imaging Criteria (Ultrasound/DMSA/MCUG), and Vesicoureteral Reflux Minimal Change Nephrotic Syndrome (Steroid Regimen & Complications) vs Acute Post-Infectious Glomerulonephritis Paediatric AKI (pRIFLE/KDIGO), Haemolytic Uraemic Syndrome (HUS), and Hyperkalaemia/Dysnatraemia Management
9 Chapter 9: Paediatric Endocrinology & Inborn Errors of Metabolism
Paediatric DKA Protocol (ISPAD/European Fluid & Insulin Guidelines, Cerebral Oedema Prevention) and T1DM Maintenance Congenital Hypothyroidism Screening & Levothyroxine, Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency), and Adrenal Crisis Short Stature Workup, Precocious vs Delayed Puberty, and Approach to Suspected Inborn Errors of Metabolism (IEM)
10 Chapter 10: Paediatric Neurology, Neurodevelopment & Mental Health
Simple vs Complex Febrile Seizures, Childhood Epilepsy Syndromes (Absence, Infantile Spasms, Benign Rolandic), and Antiseizure Medications Red Flags for Raised Intracranial Pressure (ICP), Brain Tumours, Migraine vs Tension Headache Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir) Developmental Milestones (Gross Motor, Fine Motor/Vision, Speech/Language, Social), Autism Spectrum, ADHD, and Cerebral Palsy
11 Chapter 11: Paediatric Haematology & Oncology
Microcytic Anaemia (Iron Deficiency vs Thalassaemia Trait/Mentzer Index), Haemolytic Anaemias (Spherocytosis, G6PD) Sickle Cell Crises (Vaso-occlusive, Acute Chest Syndrome, Stroke Prevention), Immune Thrombocytopenia (ITP), and Haemophilia A/B Acute Lymphoblastic Leukaemia (ALL), Neuroblastoma, Wilms Tumour, and Management of Febrile Neutropenia
12 Chapter 12: Paediatric Infectious Diseases, Immunology & Allergy
Common Childhood Exanthems: Clinical Morphology, Timelines, Complications, and Management Paediatric Tuberculosis, Sepsis Six in Children, and Acute Osteoarticular Infections Pediatric Allergy, Atopic Eczema, Food Hypersensitivity, and Desensitization Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules
13 Chapter 13: Paediatric Musculoskeletal, Dermatology & Surgical Conditions
The Limping Child, Septic Arthritis vs Transient Synovitis, and Juvenile Idiopathic Arthritis Henoch-Schönlein Purpura, Kawasaki Disease vs MIS-C, Infantile Haemangiomas, and Common Pediatric Eruptions Acute Appendicitis, Intussusception, Pyloric Stenosis, Testicular Torsion, and Incarcerated Hernia
14 Chapter 14: Research Methods, Biostatistics & Evidence-Based Paediatrics
Study Designs, Causality, Bias, and Epidemiological Measures in Paediatrics Diagnostic Test Accuracy, Statistical Inference, and Hypothesis Testing Systematic Reviews, Meta-Analysis, Decision Analysis, and Paediatric Research Ethics
15 Chapter 15: Paediatric Ophthalmology & ENT Disorders
Paediatric Vision Assessment, Refractive Disorders, Strabismus, and Leukocoria Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions
16 Chapter 16: Paediatric Sports Medicine & Musculoskeletal Health
Skeletal Maturity, Physeal Injuries, Apophysitis, and Overuse Syndromes Paediatric Sports Concussion, Second Impact Syndrome, and Return-to-Play Protocols Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance
17 Chapter 17: Adolescent Medicine & Healthcare Transition
Biopsychosocial Development, Pubertal Staging, and Adolescent Communication Adolescent Confidentiality, Risk Behaviours, Reproductive Health, and Eating Disorders Chronic Illness in Adolescence and Structured Healthcare Transition
18 Chapter 18: Paediatric Genetics, Dysmorphology & Clinical Genomics
Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes Genetic Testing Technologies, Prenatal Diagnosis, and Genetic Counselling Ethics
19 Chapter 19: Paediatric Mental Health, Behaviour & Community Medicine
Cognitive Development, Attachment, Screening, and Common Emotional Disorders Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness Community Child Healthcare Structures, Disability Coordination, and Child Advocacy
Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness
Key Takeaways Explain This Topic AI
Infant colic is clinically defined by Wessel's rule of threes in an otherwise thriving infant; clinical management prioritizes the systematic exclusion of organic mimics (corneal abrasion, hair tourniquet, non-accidental injury, cow's milk protein allergy) alongside structured parental education to prevent abusive head trauma.
Behavioural infant sleep disorders encompass sleep-onset association disorder (inability to transition to sleep without external parental props) and limit-setting sleep disorder (toddler bedtime resistance), successfully managed with behavioral extinction techniques and consistent evening routines.
DSM-5 ADHD requires ≥ 6 \ge 6 ≥ 6 symptoms in an affected domain below age 17, or ≥ 5 \ge 5 ≥ 5 from age 17 persisting for ≥ 6 \ge 6 ≥ 6 months across ≥ 2 \ge 2 ≥ 2 independent settings with onset prior to age 12; multimodal therapy combines behavioral interventions, academic accommodations, and central stimulants (methylphenidate as first-line) with rigorous cardiovascular and growth monitoring.
Autism Spectrum Disorder is characterized by persistent social communication deficits and restricted, repetitive behaviors; absence of joint attention and protodeclarative pointing by 14 to 18 months represent critical screening red flags requiring specialist developmental assessment. ADOS-2 and ADI-R may support clinical diagnosis; neither is compulsory or sufficient alone.
Functional abdominal pain and functional neurological disorder use positive clinical features with appropriate assessment. ME/CFS is a separate chronic multisystem medical condition: recognise post-exertional malaise, assess alternative causes, support energy management and avoid fixed exercise increments.
Last updated: November 2026
Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness
Paediatric practice encompasses a broad spectrum of neurodevelopmental, behavioral, and psychosomatic conditions. From early regulatory mismatches in infancy to complex neurodevelopmental disorders like ADHD and autism, and functional somatic syndromes in school-age children and adolescents, clinical competency demands sophisticated diagnostic discrimination. Modern paediatrics emphasizes replacing diagnoses of exclusion with positive clinical indicators, avoiding unnecessary invasive investigations, and delivering multimodal, family-centered therapeutic care.
Regulatory Disorders of Infancy and Early Childhood
During the first year of life, infants must achieve biological regulation across crying, sleeping, and feeding. Regulatory disorders represent mismatches between an infant's constitutional neurobehavioral threshold and their caregiving environment. [Infantile Excessive Crying Workup]
- |
- +-----------------------+-----------------------+
- | |
- [Rule Out Organic Mimics] [Confirm Infant Colic]
- | |
- Fluorescein eye exam (Corneal abrasion) - Wessel's Rule of Threes
- Digits & genitalia check (Hair tourniquet) - Thriving infant, normal growth
- Unexplained bruising / NAT screening - Peaks at 6 weeks, resolves by 3-4 months
- Cow's Milk Protein Allergy (CMPA) - PURPLE crying education
- Incarcerated hernia, acute otitis media - Safe crib placement (prevent AHT)
- 1. Infant Colic and Persistent Excessive Crying
Clinical Definition (Wessel's Rule of Threes) : Crying or fussing that lasts for more than 3 hours per day , occurs for more than 3 days per week , and persists for more than 3 weeks in an otherwise well-fed, healthy, thriving infant aged under 4 months.
Natural History : Paroxysmal bouts of crying typically begin at 2 to 3 weeks of age, peak in intensity and duration at 6 weeks of age (averaging 2.5 to 3 hours daily), and characteristically resolve spontaneously by 3 to 4 months of age .
Mandatory Exclusion of Organic Mimics :
Corneal Abrasion : Accidental self-inflicted scratches from neonatal fingernails; diagnosed via topical fluorescein staining examined under a cobalt blue light.
Hair-Apparent / Hair Tourniquet Syndrome : A stray strand of hair or fiber tightly wrapped circumferentially around a digit or the penis, causing venous congestion, ischemia, and excruciating pain.
Non-Accidental Trauma (NAT) / Abusive Head Trauma (AHT) : Skeletal trauma, rib fractures, subdurals, or retinal hemorrhages; unexplained bruising in a non-crawling infant is an absolute red flag ("those who don't cruise rarely bruise").
Cow's Milk Protein Allergy (CMPA) : Co-occurring severe atopic eczema, vomiting, microscopic or gross blood in stools, and faltering growth; warrants a 2- to 4-week trial of extensively hydrolyzed formula (eHF) or maternal elimination diet in breastfed infants.
Surgical Emergencies : Incarcerated inguinal hernia, acute testicular torsion, or intussusception (in infants > 3 >3 > 3 months).
Parental Psychoeducation and Harm Reduction :
The acronym PURPLE crying describes the normal developmental phase: P eak of crying, U nexpected, R esists soothing, P ain-like face, L ong lasting, E vening clustering.
Abusive Head Trauma Prevention : Explicitly educate parents that infant crying can induce severe exhaustion and anger. If parents feel overwhelmed, the safest action is to place the infant safely on their back in an empty crib, close the door, and step away to take a calming breath or contact adult support.
2. Behavioural Infant Sleep Disorders
Sleep-Onset Association Disorder :
Pathophysiology : The infant associates sleep onset with an external dependency (rocking, breastfeeding, bottle in mouth, driving in a car). When normal physiological brief nocturnal arousals occur every 60 to 90 minutes, the infant cannot re-enter sleep independently without the parents recreating the exact external association.
Management : Behavioral sleep techniques—such as graduated extinction ("Ferber method") or bedtime fading—teaching the infant to self-soothe by placing them in the crib drowsy but awake.
Limit-Setting Sleep Disorder :
Pathophysiology : Seen primarily in toddlers and preschoolers (ages 2 to 5 years). The child exhibits bedtime stalling, refusal to go to bed, and repetitive demands ("curtain calls" for water, another story, bathroom trips) due to inadequate parental boundaries.
Management : Establishing a structured, predictable 20- to 30-minute calming bedtime routine; consistent parental enforcement; positive reinforcement reward charts; and the "bedtime pass" technique (allowing one single return out of bed for a defined purpose).
3. Infant Feeding Disorders and Interactional Faltering Growth
In non-organic faltering growth (failure to thrive), parent-infant interactional mismatch plays a central role. Parental anxiety regarding weight gain frequently leads to high-pressure, coercive force-feeding. This induces acute distress in the infant, visceral conditioning of feeding aversion, and active food refusal, escalating parental anxiety.
Ellyn Satter’s Division of Responsibility in Feeding follows development: in infancy, caregivers choose breastmilk/formula and follow feeding cues for timing and amount; with family meals, caregivers provide what, when and where , while the child decides whether and how much . High-calorie formula concentration and multidisciplinary feeding therapy are integrated.
Attention-Deficit/Hyperactivity Disorder (ADHD)
ADHD is a highly heritable (~70–80%) neurodevelopmental disorder characterized by developmentally inappropriate, pervasive patterns of inattention, hyperactivity, and impulsivity.
DSM-5 Diagnostic Criteria
Symptom Threshold : Presence of at least 6 symptoms of inattention and/or at least 6 symptoms of hyperactivity-impulsivity (threshold reduced to 5 symptoms for adolescents aged 17 and older).
Chronicity : Symptoms must have persisted for at least 6 consecutive months to a degree inconsistent with developmental level, directly compromising social, academic, or occupational functioning.
Pervasiveness Across Settings : Symptoms must be demonstrated across at least two independent settings (e.g., home and school). Establish this through a full clinical/developmental assessment and information from more than one setting. Parent and teacher scales such as Conners or Vanderbilt support assessment; they do not independently establish the diagnosis.
Onset Before Age 12 : Several inattentive or hyperactive-impulsive symptoms must have been present prior to age 12 years.
Clinical Presentations : Predominantly Inattentive Presentation, Predominantly Hyperactive/Impulsive Presentation, or Combined Presentation (most common). [Multimodal ADHD Management]
- |
- +--------------------------------+--------------------------------+
- | |
- [Non-Pharmacological] [Pharmacological Therapy]
- | |
- Parent Behavioral Management Training - First-Line: Methylphenidate (stimulant)
- (PT/PCIT; first-line in preschool ages 4-5) - Second-Line: Lisdexamfetamine (stimulant)
- School Accommodations (IEP/504, visual schedules) - Non-stimulants: Atomoxetine (NET inhibitor),
- Environmental structuring (chunking assignments) Guanfacine (alpha-2A adrenergic agonist)
- Mandatory Monitoring: BP, HR, Height, Weight
- Multimodal Management Framework
Preschool Children (Ages 4 to 5 Years) : Evidence-based parent training in behavior management (e.g., Incredible Years, Triple P, Parent-Child Interaction Therapy [PCIT]) is the mandatory first-line intervention . Medications are reserved only for severe dysfunction unresponsive to behavioral therapy.
School-Age Children and Adolescents (Ages 6 Years and Older) : Multimodal integration of behavioral therapies, classroom accommodations (Individualized Education Plans [IEP], 504 plans, preferential seating, simplified multi-step instructions), and pharmacotherapy.
ADHD Pharmacotherapy
Medication Class Agent Mechanism of Action Clinical Indications & Strengths Primary Adverse Effects & Monitoring
Central Stimulant (First-Line) Methylphenidate Inhibits presynaptic dopamine transporter (DAT) and norepinephrine transporter (NET), elevating synaptic catecholamines Gold-standard first-line pharmacological agent across European guidelines; available in immediate-release (3–4h) and extended-release (8–12h, e.g., OROS) formulations Decreased appetite, growth deceleration, insomnia, abdominal pain, tachycardia, hypertension, motor tics. Monitor pulse/BP with dose changes and at least 6-monthly; measure height 6-monthly and weight by age (see below).
Central Stimulant (Second-Line) Lisdexamfetamine / Dexamfetamine Stimulates dopamine and norepinephrine release from presynaptic vesicles AND blocks reuptake Effective when methylphenidate response is inadequate; lisdexamfetamine is a lysine-conjugated prodrug requiring enzymatic cleavage in RBCs, reducing recreational abuse liability Similar to methylphenidate; increased sympathomimetic potency. Routine cardiac and growth monitoring required.
Non-Stimulant (SNRI) Atomoxetine Highly selective presynaptic norepinephrine reuptake inhibitor (NET blocker) Non-controlled alternative for ADHD when methylphenidate/lisdexamfetamine are not tolerated or adequate trials are ineffective; anxiety or tics alone do not automatically change first-line selection. Assess diversion risk; benefit develops over weeks Somnolence, nausea, abdominal discomfort, elevated liver enzymes (rare hepatotoxicity), suicidal ideation warning.
Non-Stimulant (Alpha-2A Agonist) Guanfacine (Extended-Release) Selective postsynaptic alpha-2A adrenergic receptor agonist in prefrontal cortex Alternative ADHD treatment when stimulant trials are ineffective or not tolerated; may be considered for stimulant-related tics after review. Specialist assessment determines use; behavioural symptoms or insomnia alone are not an indication Sedation, dizziness, hypotension, bradycardia. Must taper gradually upon discontinuation to prevent rebound hypertension .
Cardiac Safety and Somatic Growth Monitoring :
Baseline evaluation requires personal and family cardiac history (unexplained syncope, family history of sudden unexpected death < 40 <40 < 40 years, long QT syndrome, hypertrophic cardiomyopathy, Wolff-Parkinson-White). Routine baseline ECG is not mandatory in asymptomatic children with negative cardiac history, but is required if family or personal history is positive.
Stimulants suppress appetite. NICE recommends height every 6 months ; weight every 3 months at ages 10 and under , or at 3 and 6 months after starting then every 6 months in older children. Check pulse/BP before and after dose changes and every 6 months; monitor more often if concerns arise. If growth velocity declines significantly, "drug holidays" (planned treatment breaks during summer holidays) or caloric supplementation may be utilized.
Autism Spectrum Disorder (ASD)
Autism Spectrum Disorder is a heterogeneous neurodevelopmental condition defined by early-emerging social-communication impairments alongside restricted, repetitive patterns of behavior.
DSM-5 Core Diagnostic Dyad
Persistent Deficits in Social Communication and Social Interaction Across Multiple Contexts :
Social-Emotional Reciprocity : Failure of normal back-and-forth conversation, reduced sharing of interests, emotions, or affect, failure to initiate or respond to social interactions.
Nonverbal Communicative Behaviors : Poorly integrated verbal and nonverbal communication, abnormalities in eye contact, deficits in understanding and use of body language, complete lack of facial expressions.
Developing, Maintaining, and Understanding Relationships : Difficulties adjusting behavior to suit varied social contexts, difficulties in sharing imaginative play or making friends, absence of interest in peers.
Restricted, Repetitive Patterns of Behaviour, Interests, or Activities (At Least 2 of 4) :
Stereotyped or repetitive motor movements, use of objects, or speech (hand flapping, finger flicking, rocking, lining up toys, echolalia, idiosyncratic phrases).
Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal/nonverbal behavior (extreme catastrophic distress at small changes, rigid transition rituals).
Highly restricted, fixated interests that are abnormal in intensity or focus (narrow preoccupations with bus timetables, vacuum cleaner models, spinning wheels).
Hyper- or hypo-reactivity to sensory input or unusual interest in sensory aspects of the environment (aversion to specific textures, sounds, bright lights; indifference to pain/temperature; excessive smelling or touching of objects). [ASD Early Surveillance: Red Flags]
- |
- +--------------------------------+--------------------------------+
- | |
- [Communication & Interaction] [Behavioral & Developmental]
- | |
- Lack of joint attention (not following gaze) - Absence of pretend / symbolic play
- Absence of protodeclarative pointing (14-18m) - Stereotypic motor mannerisms (hand-flapping)
- Inconsistent or delayed response to name - Extreme distress over minor routine changes
- Delayed or absent social smile - REGRESSION of language / social skills (15-24m)
- Early Red Flags for Clinical Referral (Ages 12 to 24 Months)
Absence of Joint Attention : The child does not spontaneously look where an adult points, nor do they look back and forth between an interesting object and the adult to share excitement.
Absence of Protodeclarative Pointing by 14 to 18 Months : Pointing to draw another's attention to an object of shared interest ("look at the airplane!"). In contrast, children with ASD may preserve proto-imperative pointing (pointing to demand an object, or using an adult's hand as a physical tool).
Failure to Respond to Name : Inconsistent or absent orientation when the child's name is called at 12 months, despite normal peripheral hearing.
Absence of Pretend / Symbolic Play : Inability to engage in imaginative play (e.g., feeding a doll with an empty cup, pretending a wooden block is a car) by 18 to 24 months.
Developmental Regression : Any loss of previously acquired speech, babbling, or social engagement between 15 and 24 months (occurs in ~20–30% of ASD cohorts) warrants an urgent, immediate paediatric referral.
Multidisciplinary Diagnostic Evaluation and Comorbidities
Diagnostic Assessment and Tools : Combine developmental history, direct observation and information across settings with clinical judgement. ADOS-2 provides structured observation and ADI-R a detailed caregiver interview; select tools to support assessment rather than requiring both for every diagnosis.
Medical and Genetic Workup : Complete physical examination for neurocutaneous stigmata (e.g., ash-leaf macules in tuberous sclerosis); formal audiology assessment to objectively rule out sensorineural or conductive hearing loss; first-line genetic testing via Chromosomal Microarray (CMA) and FMR1 DNA testing for Fragile X syndrome .
Key Medical Comorbidities :
Epilepsy : Bimodal onset (infancy and adolescence); overall prevalence of 20–30%, particularly elevated in individuals with co-occurring intellectual disability.
Gastrointestinal Dysfunction : Chronic severe constipation, reflux, and extreme food selectivity based on sensory properties.
Sleep Disturbances : Affecting up to 70 % 70\% 70% of children with ASD; driven by endogenous abnormalities in circadian melatonin synthesis (oral melatonin is clinically effective).
Co-Occurring Psychiatric Conditions : ADHD (present in 30–50%), anxiety disorders, and intellectual disability (~30–40%).
Functional Somatic Disorders and Psychosomatic Illness
In recent clinical practice, the diagnostic approach to paediatric psychosomatic illness has evolved. Historically treated as "diagnoses of exclusion" requiring endless negative investigative cascades, conditions are now recognized through positive clinical diagnostic criteria and specific bedside physical examination findings, reflecting neurobiological dysregulation of the brain-gut and brain-body axis.
1. Functional Abdominal Pain Disorders (Rome IV Criteria)
Rome IV uses disorder-specific criteria after appropriate medical evaluation: IBS and FAP-NOS require pain at least 4 days/times monthly for 2 months; functional dyspepsia requires bothersome symptoms at least 4 days monthly for 2 months. Abdominal migraine uses the separate pattern below:
Irritable Bowel Syndrome (IBS) : Abdominal pain associated with defecation, a change in stool frequency (diarrhea or constipation), and/or a change in stool form.
Functional Dyspepsia : Persistent postprandial fullness, early satiety, epigastric pain, or burning not associated with defecation.
Abdominal Migraine : At least two stereotyped, incapacitating attacks over 6 months: intense midline, periumbilical or diffuse pain lasting at least 1 hour, separated by weeks/months, with at least two of anorexia, nausea, vomiting, headache, photophobia or pallor. Appropriate evaluation excludes another explanation.
Functional Abdominal Pain Not Otherwise Specified (NOS) : Abdominal pain that does not meet the specific criteria for IBS, dyspepsia, or abdominal migraine.
Clinical Domain Functional Abdominal Pain (Rome IV) Organic Disease (IBD, Celiac, Peptic Disease)
Pain Location & Timing Often periumbilical/diffuse; symptoms may affect school or sleep. Timing alone does not establish a functional diagnosis Persistent focal RUQ/RLQ pain or nocturnal diarrhoea warrants further assessment; organic pain need not wake the child
Growth & Systemic Signs Normal linear growth, stable weight velocity; no fever, rash, or joint swelling Involuntary weight loss, linear growth deceleration, chronic unexplained fevers, peripheral arthritis
Gastrointestinal Signs Normal stooling or functional constipation; no blood in stool Chronic severe diarrhea, gross hematochezia, melena, perianal disease (fistulas, skin tags)
Laboratory Parameters Results are usually normal; a low age-appropriate faecal calprotectin supports absence of intestinal inflammation Anaemia, raised inflammatory markers or low albumin may suggest inflammation. Raised calprotectin requires context; normal results do not exclude coeliac or peptic disease
2. Functional Neurological Disorder (FND / Conversion Disorder)
FND is defined by symptoms of altered voluntary motor or sensory function that demonstrate clear clinical incompatibility with recognized neuroanatomical or neurological disease . The diagnosis is confirmed by identifying positive physical examination signs of functional dissociation. [FND: Hoover's Sign Demonstration]
- |
- +------------------------------+------------------------------+
- | |
- [Step 1: Voluntary Test] [Step 2: Involuntary Synergistic Test]
- | |
- Patient instructed to extend paretic leg - Patient instructed to flex NORMAL leg
against examiner's hand. against resistance at the hip.
- Apparent weakness: NO extensor pressure felt - Examiner's hand under paretic heel detects
under paretic heel. ROBUST, POWERFUL downward extension force!
- Proves corticospinal tract is anatomically intact.
Positive Diagnostic Clinical Signs :
Hoover's Sign (Functional Leg Weakness): Demonstrates involuntary-voluntary motor dissociation. The patient is placed supine. When asked to press the paretic heel down into the examiner’s hand, apparent severe weakness is noted. The examiner then places a hand beneath the paretic heel and instructs the patient to forcefully flex the contralateral, healthy hip against resistance. In functional paresis, the examiner detects strong, involuntary downward hip extensor force under the paretic heel , confirming intact motor pathways.
Give-Way / Ratchety Weakness : Resistance collapses abruptly when tested, rather than displaying the smooth, continuous resistance of true upper or lower motor neuron paresis.
Sensory Boundaries : Sharp cut-off of sensory loss ending precisely at the anatomical midline or ending abruptly at joints ("glove-and-stocking" without peripheral neuropathy), defying dermatomal neuroanatomy.
Functional / Psychogenic Non-Epileptic Seizures (PNES) : Characterized by prolonged episodes ( > 15 − 30 >15-30 > 15 − 30 minutes), fluctuating wax-and-wane intensity, asynchronous out-of-phase limb flailing, side-to-side head shaking, tightly closed eyes with active resistance to eyelid opening , preserved pupillary light reflexes, pelvic thrusting, absence of postictal stertorous breathing, and an ictal surface EEG demonstrating normal background rhythm without epileptiform activity.
Management Paradigm : Delivery of the diagnosis is the primary therapeutic intervention. The physician must validate that symptoms are real and distressing, explain the concept of a reversible "software problem" of the nervous system rather than permanent structural "hardware damage," demonstrate Hoover's sign to the family to illustrate recovery potential, and prescribe specialized neurophysical rehabilitation combined with CBT.
Paediatric Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)
ME/CFS is a chronic multisystem medical condition, distinct from a diagnosis of functional neurological or psychosomatic illness.
Diagnostic Criteria (NICE) : Diagnose after 3 months in children or adults when disabling activity-worsened fatigue, post-exertional malaise, unrefreshing/disturbed sleep and cognitive difficulties persist, substantially reduce function and are not explained by another condition.
Hallmark Feature: Post-Exertional Malaise (PEM) : The absolute requirement for diagnosis. Following minor physical, cognitive, or emotional exertion, the patient experiences an acute, severe exacerbation of all symptoms ("crash"), characteristically delayed by 12 to 48 hours and persisting for days or weeks.
Associated Manifestations : Orthostatic intolerance (manifesting as postural orthostatic tachycardia syndrome [POTS]), unrefreshing sleep, cognitive impairment ("brain fog," delayed processing speed), chronic headaches, and widespread musculoskeletal pain.
Assessment for Alternative Causes : Perform history, examination and screening such as blood count, renal/liver/thyroid function, inflammatory markers, ferritin, coeliac testing, glucose/HbA1c, calcium/phosphate, CK and urinalysis. Add infection serology or morning cortisol when the clinical history suggests an indication.
Management : Reassurance; non-judgmental biopsychosocial formulation; energy pacing (staying within the patient's "energy envelope" to prevent boom-and-bust cycles); gradual, collaborative return to school; sleep hygiene; and optional CBT to support symptom management if the patient wishes. Adjust activity within energy limits; do not prescribe fixed incremental exercise increases.